REQUEST A DEMO
Total
USD $0.00
Search more companies

Medlamp-Rtg Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Medlamp-Rtg Sp. z o.o. Profile Updated: May 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Medlamp-Rtg Sp. z o.o. is a company in Poland, with a head office in Zgierz. It operates in the Pharmacies and Drug Stores industry. The company was established on January 05, 2022. In its most recent financial highlights, the company reported a net sales revenue drop of 66.2% in 2023. Its’ total assets recorded a growth of 75.04%. Medlamp-Rtg Sp. z o.o.’s net profit margin increased by 15.08% in 2023.

Headquarters
Ul. Karpacka 1A
Zgierz; Lodzkie; Postal Code: 95-100

Contact Details: Purchase the Medlamp-Rtg Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medlamp-Rtg Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medlamp-Rtg Sp. z o.o. report to view the information.
Incorporation Date:
January 05, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Medlamp-Rtg Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-66.2%
Total operating revenue
-65.95%
Operating profit (EBIT)
-54.97%
Net Profit (Loss) for the Period
-53.92%
Total assets
75.04%
Total equity
43.93%
Operating Profit Margin (ROS)
15.53%
Net Profit Margin
15.08%
Return on Equity (ROE)
-64.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?